Voyager Therapeutics Inc (NASDAQ: VYGR) on Monday, plunged -5.00% from the previous trading day, before settling in for the closing price of $7.00. Within the past 52 weeks, VYGR’s price has moved between $5.71 and $11.72.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 355.29% over the last five years. The company achieved an average annual earnings per share of -144.20%. With a float of $45.09 million, this company’s outstanding shares have now reached $54.53 million.
The firm has a total of 162 workers. Let’s measure their productivity. In terms of profitability, gross margin is 96.61%, operating margin of -4.63%, and the pretax margin is 6.75%.
Voyager Therapeutics Inc (VYGR) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Voyager Therapeutics Inc is 17.32%, while institutional ownership is 68.20%. The most recent insider transaction that took place on Oct 02 ’24, was worth 34,914. In this transaction Chief Legal Officer of this company sold 5,999 shares at a rate of $5.82, taking the stock ownership to the 86,001 shares. Before that another transaction happened on Oct 02 ’24, when Company’s Officer proposed sale 5,999 for $5.82, making the entire transaction worth $34,920.
Voyager Therapeutics Inc (VYGR) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -144.20% per share during the next fiscal year.
Voyager Therapeutics Inc (NASDAQ: VYGR) Trading Performance Indicators
Voyager Therapeutics Inc (VYGR) is currently performing well based on its current performance indicators. A quick ratio of 9.51 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.29, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -1.68 in one year’s time.
Technical Analysis of Voyager Therapeutics Inc (VYGR)
Analysing the last 5-days average volume posted by the [Voyager Therapeutics Inc, VYGR], we can find that recorded value of 0.67 million was better than the volume posted last year of 0.65 million. As of the previous 9 days, the stock’s Stochastic %D was 50.04%. Additionally, its Average True Range was 0.47.
During the past 100 days, Voyager Therapeutics Inc’s (VYGR) raw stochastic average was set at 24.48%, which indicates a significant decrease from 25.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 118.12% in the past 14 days, which was higher than the 70.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.57, while its 200-day Moving Average is $7.85. Now, the first resistance to watch is $7.04. This is followed by the second major resistance level at $7.43. The third major resistance level sits at $7.63. If the price goes on to break the first support level at $6.45, it is likely to go to the next support level at $6.25. Should the price break the second support level, the third support level stands at $5.86.
Voyager Therapeutics Inc (NASDAQ: VYGR) Key Stats
Market capitalization of the company is 371.67 million based on 54,533K outstanding shares. Right now, sales total 250,010 K and income totals 132,330 K. The company made 29,580 K in profit during its latest quarter, and -10,140 K in sales during its previous quarter.
